PedAM
Pediatric Disease Annotations & Medicines
| Disease | myasthenia gravis |
| Phenotype | C0040100|thymomas |
| Sentences | 7 |
| PubMedID- 21861913 | Calcification in thymomas in association with myasthenia gravis has been stated in 7-25% of patients [3,4,19]. |
| PubMedID- 26273358 | Approximately 40% of thymomas are complicated with myasthenia gravis (mg), significantly relating to type ab, b2, and b3.1 the occurrence of a thymoma complicated with mg may be caused by changes in the thymic microenvironment of tumor formation, and the symptoms of complicated myasthenia are usually more serious than mere mg. although thymomas have a low mortality rate and a low degree of malignancy characteristics, the incidence of second cancers are increased in patients with a thymoma.2 the cause of thymoma is not yet clear, but several studies have indicated that the epstein–barr virus3 and genetic aberration4–8 may play an important role in the pathogenesis of thymomas. |
| PubMedID- 26413313 | thymomas are associated with myasthenia gravis and approximately 15–20% of patients with thymoma have clinical symptoms while another 25% have elevated biomarkers (2). |
| PubMedID- 21879277 | Different characteristics of thymomas with and without myasthenia gravis. |
| PubMedID- 21092589 | thymomas associated with myasthenia gravis contain a significant population of cd20-positive intra-tumoral b lymphocytes. |
| PubMedID- 21070986 | myasthenia gravis (mg) associated with thymomas differs from nonthymomatous mg, and thymomas associated with mg are also different from non-mg thymomas. |
| PubMedID- 22966376 | We retrospectively studied 73 patients with completely resected thymomas unassociated with myasthenia gravis. |
Page: 1